Pernix Therapeutics Holdings (PTX) Posts Q2 Loss of 16c/Share
Tweet Send to a Friend
Pernix Therapeutics Holdings (NASDAQ: PTX) reported Q2 EPS of ($0.16), $0.03 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
